Patent details

91710 Product Name: Pazopanib, facultativement sous forme d'un sel ou d'un solvate pharmaceutiquement acceptable de celui-ci (VOTRIENT®)

Basic Information

Publication number:
91710
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP019943158
Legal Status:
Expired
Application number:
91710
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
18/01/2022
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
04/10/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/10/628/001-004
Marketing Authorization Type:
Marketing Authorization Date:
16/06/2010
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
21/07/2010
First Marketing Authorization date:
16/06/2010
Grant date:
21/09/2010
Activation date:
19/12/2021
Publication date:
21/09/2010
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
16/06/2025
SPC Extension Expiration:
16/12/2025
Rejection date:
Withdrawal date:

Owner

From:
17/12/2015
 
 

Name:
NOVARTIS AG
Address:
LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)

History of Owners

From:
17/12/2015
To:
17/12/2015

Name:
LEO OSPREY LIMITED
Address:
980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)

From:
21/07/2010
To:
16/12/2015

Name:
GlaxoSmithKline LLC
Address:
One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/07/2010
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
VEAL James, Martin GlaxoSmithKline
Address:
United States (US)

2

Name:
HARRIS Philip, Anthony GlaxoSmithKline
Address:
United States (US)

3

Name:
BOLOOR Amogh
Address:
United States (US)

4

Name:
DAVIS Ronda GlaxoSmithKline
Address:
United States (US)

5

Name:
CHEUNG Mui GlaxoSmithKline
Address:
United States (US)

6

Name:
MOOK Robert, Anthony,Jr. GlaxoSmithKline
Address:
United States (US)

7

Name:
HINKLE Kevin GlaxoSmithKline
Address:
United States (US)

8

Name:
STAFFORD Jeffery, Alan GlaxoSmithKline
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2022/02
Publication date:
01/02/2022
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

4

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
13/12/2024
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
CPA GLOBAL THE IP PLATFORM